Alfa-2b interferon in the treatment of Hodgkin's disease and non-Hodgkin's lymphoma.
D000917:Antibody Formation; D001772:Blood Cell Count / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D006689:Hodgkin Disease / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy; D007370:Interferon Type I / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use*; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy*; D009500:Neutralization Tests
D007370:Interferon Type I